Shine-On BioMedical Co.,Ltd. (TPEX:6926)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
66.90
0.00 (0.00%)
Mar 24, 2026, 12:20 PM CST

Shine-On BioMedical Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
49.1744.66102.02373.16824.98
Short-Term Investments
8739991,03579381
Cash & Short-Term Investments
922.171,0441,1371,166905.98
Cash Growth
-11.64%-8.21%-2.50%28.72%-
Accounts Receivable
--10--
Other Receivables
2.742.312.061.18-
Receivables
2.742.3112.061.18-
Prepaid Expenses
10.156.344.571.490.32
Other Current Assets
---0-
Total Current Assets
935.061,0521,1541,169906.31
Property, Plant & Equipment
1.42.831.543.033.99
Other Intangible Assets
9.023.623.593.361.24
Long-Term Deferred Tax Assets
--0.042.27-
Other Long-Term Assets
5.461.030.890.280.28
Total Assets
950.941,0601,1601,178911.82
Accounts Payable
--2.86-0.19
Accrued Expenses
-0.260.570.011
Current Portion of Leases
1.361.240.540.540.97
Other Current Liabilities
42.1839.0919.292.610.59
Total Current Liabilities
43.5440.623.263.172.74
Long-Term Leases
-1.36-0.981.52
Long-Term Deferred Tax Liabilities
0.120.26---
Total Liabilities
43.6642.2123.264.144.26
Common Stock
498498498498430
Additional Paid-In Capital
703.6703.6703.6703.6486
Retained Earnings
-294.32-184.03-65.14-27.98-8.43
Shareholders' Equity
907.281,0181,1361,174907.57
Total Liabilities & Equity
950.941,0601,1601,178911.82
Total Debt
1.362.60.541.522.48
Net Cash (Debt)
920.811,0411,1361,165903.5
Net Cash Growth
-11.55%-8.40%-2.42%28.90%-
Net Cash Per Share
18.4520.9022.8225.6548.91
Filing Date Shares Outstanding
50.0149.849.849.849.8
Total Common Shares Outstanding
50.0149.849.849.849.8
Working Capital
891.531,0121,1301,166903.57
Book Value Per Share
18.1420.4322.8223.5718.22
Tangible Book Value
898.261,0141,1331,170906.33
Tangible Book Value Per Share
17.9620.3622.7523.5018.20
Machinery
-1.231.861.791.31
Leasehold Improvements
-0.020.370.370.37
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.